Biondvax制药(BVXV)

1.36 0.00 0.0%

今开:0.0昨收:1.36
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4942788.0

Biondvax制药的最新讨论

艾因y662021-02-08 12:03

$Biondvax制药(BVXV)$ 2-8 4.47建仓 看8查看全文

SM_美股投机军曹2021-01-22 07:29

$实战刷盈利2(ZH2416493)$ @SM_美股投机军曹 $Biondvax制药(BVXV)$
盘后下跌完全不合理. 翻倍只是时间问题. 短期吧.查看全文

LAES1682020-12-06 00:17

$Biondvax制药(BVXV)$低位上来有20%舍不得走,填空空间太大,贪婪一下。查看全文

LAES1682020-12-05 04:48

$Biondvax制药(BVXV)$boom,有个大的填空题喔$道琼斯指数(.DJI)$查看全文

魔都弗兰克2020-10-25 17:26

$Biondvax制药(BVXV)$what the F,这么惨烈,本来还有点期待通用流感疫苗,当初赚五个点就走人了,太难了,太险了查看全文

美股马甲2020-10-24 05:28

$Biondvax制药(BVXV)$ 流感疫苗三期挂了,股价脚踝斩。二期成功了,T cell immune response也观察到了,然而还是不行。MRNA如果挂了,场面一定不忍直视。查看全文

割资本主义羊毛2015-09-02 21:30

$BiondVax Pharmaceuticals Ltd. - American Depositary Shares(BVXV)$ Announces Planned Launch of Multimeric-001 Phase 2,“Planned”=60%!!!小药股吹票节操线又晋新low。查看全文

Biondvax制药的公告

当期报告

$Biondvax制药(BVXV)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-23-036129  Act: 34  Size: 11 MB 网页链接

员工持股计划

$Biondvax制药(BVXV)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-23-030288  Act: 33  Size: 155 KB 网页链接

年度财报

$Biondvax制药(BVXV)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-23-030228  Act: 34  Size: 12 MB 网页链接

其他

$Biondvax制药(BVXV)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-23-025894  Act: 34  Size: 32 KB 网页链接

超过5%股东持股披露「修订」

$Biondvax制药(BVXV)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001567619-23-001890  Act: 34  Size: 65 KB 网页链接

财报披露

$Biondvax制药(BVXV)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-004305  Act: 34  Size: 79 KB 网页链接

首次持股声明「修正」

$Biondvax制药(BVXV)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001213900-23-004285  Size: 7 KB 网页链接

首次持股声明「修正」

$Biondvax制药(BVXV)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001213900-23-004283  Size: 7 KB 网页链接

首次持股声明「修正」

$Biondvax制药(BVXV)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001213900-23-004280  Size: 7 KB 网页链接

首次持股声明「修正」

$Biondvax制药(BVXV)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001213900-23-004276  Size: 8 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30